Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Proto Labs (PRLB) over the last 15 years, with Q3 2025 value amounting to $104.4 million.

  • Proto Labs' Cash & Equivalents rose 1883.29% to $104.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.4 million, marking a year-over-year increase of 1883.29%. This contributed to the annual value of $89.1 million for FY2024, which is 630.27% up from last year.
  • Latest data reveals that Proto Labs reported Cash & Equivalents of $104.4 million as of Q3 2025, which was up 1883.29% from $90.4 million recorded in Q2 2025.
  • In the past 5 years, Proto Labs' Cash & Equivalents ranged from a high of $104.4 million in Q3 2025 and a low of $41.9 million during Q2 2021
  • Over the past 5 years, Proto Labs' median Cash & Equivalents value was $66.5 million (recorded in 2023), while the average stood at $71.9 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 5957.68% in 2021, then surged by 4956.08% in 2024.
  • Over the past 5 years, Proto Labs' Cash & Equivalents (Quarter) stood at $65.9 million in 2021, then decreased by 14.21% to $56.6 million in 2022, then surged by 48.15% to $83.8 million in 2023, then rose by 6.3% to $89.1 million in 2024, then grew by 17.23% to $104.4 million in 2025.
  • Its Cash & Equivalents stands at $104.4 million for Q3 2025, versus $90.4 million for Q2 2025 and $82.7 million for Q1 2025.